RadNet Inc (RDNT) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.062x

Based on the latest financial reports, RadNet Inc (RDNT) has a cash flow conversion efficiency ratio of 0.062x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($84.16 Million) by net assets ($1.36 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

RadNet Inc - Cash Flow Conversion Efficiency Trend (1995–2025)

This chart illustrates how RadNet Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read debt load of RadNet Inc for a breakdown of total debt and financial obligations.

RadNet Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of RadNet Inc ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Suven Pharmaceuticals Limited
NSE:SUVENPHAR
0.014x
KONINKLIJKE VOP.UNSP.ADR
F:VPK
N/A
Brown-Forman Corporation
NYSE:BF-A
0.102x
Grupo Aeroportuario del Centro Norte SAB de CV
NASDAQ:OMAB
0.162x
MDU Resources Group Inc
NYSE:MDU
0.008x
Clear Secure Inc
NYSE:YOU
-0.285x
Charoen Pokphand Foods Public Company Limited
F:NVAV
0.058x
Beijing Roborock Technology Co Ltd
SHG:688169
-0.015x

Annual Cash Flow Conversion Efficiency for RadNet Inc (1995–2025)

The table below shows the annual cash flow conversion efficiency of RadNet Inc from 1995 to 2025. For the full company profile with market capitalisation and key ratios, see RDNT stock market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 $1.36 Billion $298.82 Million 0.220x +7.20%
2024-12-31 $1.13 Billion $233.02 Million 0.206x -24.29%
2023-12-31 $813.36 Million $220.86 Million 0.272x -8.86%
2022-12-31 $491.45 Million $146.42 Million 0.298x -31.01%
2021-12-31 $346.16 Million $149.49 Million 0.432x -52.28%
2020-12-31 $258.30 Million $233.76 Million 0.905x +102.25%
2019-12-31 $233.14 Million $104.32 Million 0.447x -23.25%
2018-12-31 $200.25 Million $116.75 Million 0.583x -71.12%
2017-12-31 $69.92 Million $141.19 Million 2.019x +14.74%
2016-12-31 $52.05 Million $91.60 Million 1.760x -4.29%
2015-12-31 $36.46 Million $67.04 Million 1.839x -76.80%
2014-12-31 $7.70 Million $61.00 Million 7.925x -73.63%
2013-12-31 $2.21 Million $66.42 Million 30.055x +181.23%
2012-12-31 $-2.00 Million $74.03 Million -36.998x -4381.09%
2011-12-31 $-69.81 Million $57.64 Million -0.826x -1.81%
2010-12-31 $-82.47 Million $66.88 Million -0.811x +20.87%
2009-12-31 $-74.76 Million $76.62 Million -1.025x -83.72%
2008-12-31 $-81.03 Million $45.20 Million -0.558x -33.00%
2007-12-31 $-69.62 Million $29.20 Million -0.419x -222.38%
2006-12-31 $-78.79 Million $10.25 Million -0.130x +58.23%
2005-12-31 $-70.63 Million $22.00 Million -0.311x -27.41%
2004-12-31 $-69.75 Million $17.05 Million -0.244x +36.74%
2003-12-31 $-52.45 Million $20.27 Million -0.386x -39.45%
2002-12-31 $-49.42 Million $13.70 Million -0.277x +9.22%
2001-12-31 $-44.50 Million $13.59 Million -0.305x -123.34%
2000-12-31 $-59.30 Million $8.11 Million -0.137x -692.84%
1999-12-31 $-63.80 Million $1.10 Million -0.017x -163.42%
1998-12-31 $-54.68 Million $-1.49 Million 0.027x -77.74%
1997-12-31 $-23.50 Million $-2.87 Million 0.122x +195.20%
1996-12-31 $-23.52 Million $-973.02K 0.041x +104.95%
1995-12-31 $-14.22 Million $11.88 Million -0.836x --

About RadNet Inc

NASDAQ:RDNT USA Diagnostics & Research
Market Cap
$4.40 Billion
Market Cap Rank
#3909 Global
#1303 in USA
Share Price
$56.85
Change (1 day)
+0.53%
52-Week Range
$52.53 - $84.48
All Time High
$86.38
About

RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States and internationally. The company operates in two segments, Imaging Centers and Digital Health. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other r… Read more